{"id":"W4411371017","doi":"10.1016/j.ijregi.2025.100685","title":"Real-world effectiveness, safety, and health-related quality of life in people living with HIV receiving bictegravir/emtricitabine/tenofovir alafenamide—12-month results of the BICSTaR French cohort","year":2025,"lang":"en","type":"article","venue":"IJID Regions","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Centers for Disease Control and Prevention; Académie canadienne du génie; Gilead Sciences","keywords":"Emtricitabine; Tenofovir alafenamide; Tenofovir; Human immunodeficiency virus (HIV); Medicine; Quality of life (healthcare); Gerontology; Virology; Antiretroviral therapy; Viral load; Nursing","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001859369,0.0002620204,0.001041464,0.0004834225,0.0001791797,0.000009025831,0.0001423752,0.000105495,0.000006427838],"category_scores_gemma":[0.0006713797,0.0001697116,0.0001136618,0.001934492,0.0002108889,0.00007023432,0.0001260719,0.0003061568,0.000001250846],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004539186,"about_ca_system_score_gemma":0.001439288,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.0193955,"about_ca_topic_score_gemma":0.04919514,"domain_scores_codex":[0.9971746,0.0005323907,0.001145105,0.0004452787,0.0003648343,0.0003378223],"domain_scores_gemma":[0.9973665,0.00124258,0.0005103775,0.000596427,0.0001489147,0.0001352362],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004798859,0.0003797213,0.9933285,0.0004708362,0.0003429252,0.000005274626,0.002151023,0.00006172501,0.00009706998,0.001438326,0.0008618212,0.0003829415],"study_design_scores_gemma":[0.004144025,0.0001087787,0.9906669,0.003871223,0.000134563,0.000004407861,0.0003037073,0.000087198,0.0001047272,0.0002089615,0.000223236,0.0001422444],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9723805,0.0006599718,0.0001276818,0.01513029,0.000104751,0.001701602,0.00004940549,0.00005871658,0.009787081],"genre_scores_gemma":[0.9880682,0.0008631787,0.0005157439,0.00005646935,0.0000112287,0.00005153617,0.00005946186,0.00002267401,0.01035146],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02979964,"threshold_uncertainty_score":0.9871345,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01703351714735733,"score_gpt":0.2806934782747568,"score_spread":0.2636599611273994,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}